Clinical Trial Update: Open-label Study of Cenobamate Monotherapy in Adult Subjects With Newly Diagnosed or Recurrent Partial-Onset Epilepsy [Phase 4]

View source ↗

Summary

Open-label Phase 4 study evaluating cenobamate monotherapy in adults with newly diagnosed or recurrent partial-onset epilepsy; the trial is currently active but…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Partial-onset Epilepsy

Drugs mentioned

• Cenobamate (cenobamate)

Snippet

Sponsor: SK Life Science, Inc. | Conditions: Focal Onset Seizure | Phase 4 | Status: ACTIVE_NOT_RECRUITING